Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

NCT04392375 PHASE4 COMPLETED Results posted

This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to placebo in 110 patients after decision has been made to proceed with induction of labor for the diagnosis of preeclampsia with severe features.

Details

Lead sponsor	Ohio State University
Phase	PHASE4
Status	COMPLETED
Enrolment	110
Start date	Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Preeclampsia Severe

Interventions

• Nifedipine 30 MG
• Placebos

Countries

United States